Sarepta surges after FDA panel backs Duchenne gene therapy
Go back to Sarepta surges after FDA panel backs Duchenne gene therapy| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.95 -1.57 (7.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.52 | 52 Week High | $63.73 | |||
| Open | $20.54 | 52 Week Low | $8.00 | |||
| Day High | $20.54 | P/E | N/A | |||
| Day Low | $18.68 | EPS | $-5.69 | |||
| Volume | 3,029,000 | |||||
